Back to Journals » Pharmacogenomics and Personalized Medicine
Pharmacogenomics and Personalized Medicine
ISSN: 1178-7066
- View all (650)
- Volume 17, 2024 (29)
- Volume 16, 2023 (97)
- Volume 15, 2022 (82)
- Volume 14, 2021 (155)
- Volume 13, 2020 (72)
- Volume 12, 2019 (34)
- Volume 11, 2018 (24)
- Volume 10, 2017 (31)
- Volume 9, 2016 (14)
- Volume 8, 2015 (16)
- Volume 7, 2014 (37)
- Volume 6, 2013 (15)
- Volume 5, 2012 (12)
- Volume 4, 2011 (10)
- Volume 3, 2010 (11)
- Volume 2, 2009 (9)
- Volume 1, 2008 (2)
Journal Articles:
- 650 records -
Mitochondrial Diabetes May Not Be the Only Phenotypic Presentation of the m.5826A>G mtDNA Variant [Letter]
Finsterer J
Pharmacogenomics and Personalized Medicine 2024, 17:401-402
Published Date: 25 July 2024
M2 Macrophage Classification of Colorectal Cancer Reveals Intrinsic Connections with Metabolism Reprogramming and Clinical Characteristics
Huang F, Wang Y, Shao Y, Zhang R, Li M, Liu L, Zhao Q
Pharmacogenomics and Personalized Medicine 2024, 17:383-399
Published Date: 11 July 2024
Identification and Validation of Glycosylation-Related Genes in Obesity and MASH: Insights from Human Liver Samples and a High-Fat Diet Mouse Model
Yu W, Chen J, Jin S, Fan X, Cai X
Pharmacogenomics and Personalized Medicine 2024, 17:363-381
Published Date: 5 July 2024
The Role of Pharmacogenomics Studies for Precision Medicine Among Ethiopian Patients and Their Clinical Implications: A Scoping Review
Getahun KA, Angaw DA, Asres MS, Kahaliw W, Petros Z, Abay SM, Yimer G, Berhane N
Pharmacogenomics and Personalized Medicine 2024, 17:347-361
Published Date: 1 July 2024
Influence of Long Non-Coding RNAs on Human Oocyte Development
Wang L, Li B, Cheng D
Pharmacogenomics and Personalized Medicine 2024, 17:337-345
Published Date: 1 July 2024
Cuproptosis-Related lncRNA Predict Prognosis and Immune Response of LUAD
Zhou Q, Liu Y, Gao Y, Quan L, Wang L, Wang H
Pharmacogenomics and Personalized Medicine 2024, 17:319-336
Published Date: 25 June 2024
Preliminary Study on Clinical Characteristics and Pathogenesis of IQSEC2 Mutations Patients
Ren Y, Luo X, Tong H, Wang S, Yan J, Lin L, Chen Y
Pharmacogenomics and Personalized Medicine 2024, 17:289-318
Published Date: 29 May 2024
The Correlation of Centromere Protein Q with Diagnosis and Prognosis in Hepatocellular Carcinoma
He K, Xie MY, Gao XJ, Wang H, Li JD
Pharmacogenomics and Personalized Medicine 2024, 17:271-288
Published Date: 27 May 2024
An Aging-Related lncRNA Signature Establishing for Breast Cancer Prognosis and Immunotherapy Responsiveness Prediction
Zhou Y, Yang Z, Zeng H
Pharmacogenomics and Personalized Medicine 2024, 17:251-270
Published Date: 23 May 2024
16S rRNA Gene Sequencing of Gut Microbiota in Rheumatoid Arthritis Treated with 99Tc-MDP
Huang Z, Chen C, Tan L, Ling Y, Ma W, Zhang J
Pharmacogenomics and Personalized Medicine 2024, 17:237-249
Published Date: 23 May 2024
Evaluation of CYP2C19 Genetic Variant and Its Lack of Association with Valproic Acid Plasma Concentrations Among Zhuang and Han Schizophrenia Patients in Guangxi
Teng JM, Qin S, Lu D, Gu Y, Tang SJ, Yan Q, Yao J, Zhang C
Pharmacogenomics and Personalized Medicine 2024, 17:225-236
Published Date: 14 May 2024
To Investigate the Influence of Smoking Cessation Intention and Common Downstream Variants of HDAC9 Gene on Large Artery Atherosclerotic Cerebral Infarction
Yu L, Zhao Y
Pharmacogenomics and Personalized Medicine 2024, 17:215-224
Published Date: 13 May 2024
Understanding Gene Involvement in Hepatocellular Carcinoma: Implications for Gene Therapy and Personalized Medicine
Younis MA, Harashima H
Pharmacogenomics and Personalized Medicine 2024, 17:193-213
Published Date: 7 May 2024
Association of the Reduced Function Met420del Polymorphism of SLC22A1 with Metformin-Induced Gastrointestinal Intolerance in Ethiopian Patients with Type 2 Diabetes Mellitus
Degaga A, Sirgu S, Huri HZ, Sim MS, Loganadan NK, Kebede T, Tegene B, Engidawork E, Shibeshi W
Pharmacogenomics and Personalized Medicine 2024, 17:183-191
Published Date: 3 May 2024
Three Liquid-Liquid Phase Separation-Related Genes Associated with Prognosis in Glioma
Lv L, Zhang X, Liu Y, Zhu X, Pan R, Huang L
Pharmacogenomics and Personalized Medicine 2024, 17:171-181
Published Date: 22 April 2024
ACE Gene Mutations (rs577350502) in Early-Onset and Recurrent Myocardial Infarction: A Case Report and Review
Deng X, Guo X, Chen X, Zeng X, Guo J, Bai X, Zhang P, Wang Y
Pharmacogenomics and Personalized Medicine 2024, 17:163-169
Published Date: 20 April 2024
Identification of a Novel Mitochondrial tRNA Mutation in Chinese Family with Type 2 Diabetes Mellitus
Li X, Shang J, Li S, Wang Y
Pharmacogenomics and Personalized Medicine 2024, 17:149-161
Published Date: 17 April 2024
Downregulation of NAT1 Expression is Associated with Poor Prognosis and Immune Infiltration in COAD
Xu H, Zhang H, Sun S, Zhang J, Huo J, Zhou C
Pharmacogenomics and Personalized Medicine 2024, 17:133-148
Published Date: 16 April 2024
Severe Vincristine-Induced Peripheral Neuropathic Weakness in Both Lower Limbs in an Asian Adolescent with CYP3A4 rs2740574 TT Genotype
Zhang D, Bai J
Pharmacogenomics and Personalized Medicine 2024, 17:125-131
Published Date: 16 April 2024
Identification of Lower Grade Glioma Antigens Based on Ferroptosis Status for mRNA Vaccine Development
Zhao Z, Xing N, Guo H, Li J, Sun G
Pharmacogenomics and Personalized Medicine 2024, 17:105-123
Published Date: 11 April 2024
Exploration of the Correlation Between GRHL1 Expression and Tumor Microenvironment in Endometrial Cancer and Immunotherapy
Guo S, Bai W, Cui F, Chen X, Fang X, Shen H, Gu X
Pharmacogenomics and Personalized Medicine 2024, 17:91-103
Published Date: 3 April 2024
The Association Between Mitochondrial tRNAGlu Variants and Hearing Loss: A Case-Control Study
Yu X, Li S, Guo Q, Leng J, Ding Y
Pharmacogenomics and Personalized Medicine 2024, 17:77-89
Published Date: 28 March 2024
Natural Language Processing for Radiation Oncology: Personalizing Treatment Pathways
Lin H, Ni L, Phuong C, Hong JC
Pharmacogenomics and Personalized Medicine 2024, 17:65-76
Published Date: 13 February 2024
Pharmacogenomic Analysis of CYP3A5*3 and Tacrolimus Trough Concentrations in Vietnamese Renal Transplant Outcomes
Nguyen TVA, Le BH, Nguyen MT, Le VT, Tran VT, Le DT, Vu DAM, Truong QK, Le TH, Nguyen HTL
Pharmacogenomics and Personalized Medicine 2024, 17:53-64
Published Date: 3 February 2024
Response to: “Challenges in DPYD Test Implementation in Patients Treated with Fluoropyirimidines, is DPYD Genotype Arriving on Time?” [Response to Letter]
Montrasio C, Cheli S, Clementi E
Pharmacogenomics and Personalized Medicine 2024, 17:51-52
Published Date: 30 January 2024
The Impact of Opioid Receptor Gene Polymorphism on Fentanyl and Alfentanil’s Analgesic Effects in the Pediatric Perioperative Period
Lilic J, Marjanovic VG, Budic I, Stefanovic N, Stokanovic D, Marjanovic GT, Jevtovic-Stoimenov T, Golubovic M, Zecevic M, Velickovic-Radovanovic R
Pharmacogenomics and Personalized Medicine 2024, 17:41-49
Published Date: 30 January 2024
FBLN5 as One Presumably Prognostic Gene Potentially Modulating Tumor Immune Microenvironment for Renal Clear Cell Carcinoma in Children and Young Adults
Zhang M, Chen F, Feng S, Liu X, Wang Z, Shen N, Meng L, Zhu D, Zhu Z
Pharmacogenomics and Personalized Medicine 2024, 17:27-40
Published Date: 19 January 2024
Maternally Inherited Essential Hypertension May Be Associated with the Mutations in Mitochondrial tRNAGlu Gene
Wang C, Deng X, Li L, Li M
Pharmacogenomics and Personalized Medicine 2024, 17:13-26
Published Date: 9 January 2024
circPVT1 Inhibits the Proliferation and Aids in Prediction of the Prognosis of Bladder Cancer
Zhou H, Cui X, Zhu L, Xu Z, Wang Z, Shao J
Pharmacogenomics and Personalized Medicine 2024, 17:1-11
Published Date: 5 January 2024
Identification of Novel Prognostic Biomarkers That are Associated with Immune Microenvironment Based on GABA-Related Molecular Subtypes in Gastric Cancer [Corrigendum]
Wang B, Huang L, Ye S, Zheng Z, Liao S
Pharmacogenomics and Personalized Medicine 2023, 16:1149-1150
Published Date: 29 December 2023
Challenges in DPYD Test Implementation in Patients Treated with Fluoropyrimidines are DPYD Genotype Arriving on Time? [Letter]
López López-Cepero M, Obrador de Hevia A, Guillot Morales M
Pharmacogenomics and Personalized Medicine 2023, 16:1145-1147
Published Date: 28 December 2023
Heme Metabolism-Related Gene TENT5C is a Prognostic Marker and Investigating Its Immunological Role in Colon Cancer
Han W, Li C, Wang Y, Huo B, Li W, Shi W
Pharmacogenomics and Personalized Medicine 2023, 16:1127-1143
Published Date: 23 December 2023
BICDL1 Predicts Poor Prognosis and is Correlated with Methylation and Immune Infiltration in Colorectal Cancer
Luo H, Luo J, Ding N, Zhang T, He Y
Pharmacogenomics and Personalized Medicine 2023, 16:1109-1126
Published Date: 22 December 2023
Olanzapine Pharmacokinetics: A Clinical Review of Current Insights and Remaining Questions
Kolli P, Kelley G, Rosales M, Faden J, Serdenes R
Pharmacogenomics and Personalized Medicine 2023, 16:1097-1108
Published Date: 21 December 2023
A Case of Floating-Harbor Syndrome with “Growth and Language Development Delay” as Its Clinical Manifestation
Yang YC, Tang Q, Yan LJ, Zhang SB, Ye XM, Gong D, Zou L, Wen XL
Pharmacogenomics and Personalized Medicine 2023, 16:1091-1096
Published Date: 15 December 2023
Circ_0000140 Alters miR-527/SLC7A11-Mediated Ferroptosis to Influence Oral Squamous Cell Carcinoma Cell Resistance to DDP
Ma Y, Gao J, Guo H
Pharmacogenomics and Personalized Medicine 2023, 16:1079-1089
Published Date: 13 December 2023
A Review on Probable Causes of Cardiotoxicity Caused by Common Cancer Drugs and the Role of Traditional Chinese Medicine in Prevention and Treatment
Zhou M, Wang W, Weng J, Lai Z
Pharmacogenomics and Personalized Medicine 2023, 16:1067-1077
Published Date: 6 December 2023
Novel Autophagy-Related Blood Biomarkers Associated with Immune Cell Infiltration in Ankylosing Spondylitis
Song H, Liu H, Li X, Lv B, Tang Z, Chen Q, Zhang D, Wang F
Pharmacogenomics and Personalized Medicine 2023, 16:1055-1066
Published Date: 5 December 2023
Identification of P3H1 as a Predictive Prognostic Biomarker for Bladder Urothelial Carcinoma Based on the Cancer Genome Atlas Database
Zhang Y, Chen Y, Chen Z, Zhou X, Chen S, Lan K, Wang Z, Zhang Y
Pharmacogenomics and Personalized Medicine 2023, 16:1041-1053
Published Date: 1 December 2023
Implication of KDR Polymorphism rs2071559 on Therapeutic Outcomes and Safety of Postoperative Patients with Gastric Cancer Who Received S-1-Based Adjuvant Chemotherapy: A Real-World Exploratory Study
Meng L, Cao J, Kang L, Xu G, Yuan DW, Li K, Zhu K
Pharmacogenomics and Personalized Medicine 2023, 16:1027-1039
Published Date: 28 November 2023
Clinical Characteristics and Prognosis of Acute Myeloid Leukemia Patients with Protein Tyrosine Phosphatase Non-Receptor Type 11 Gene Mutation
Huang R, Zhang YT, Lin Y, Pang RL, Yang Z, Zhao WH
Pharmacogenomics and Personalized Medicine 2023, 16:1011-1026
Published Date: 11 November 2023
PLP2 Could Be a Prognostic Biomarker and Potential Treatment Target in Glioblastoma Multiforme
Qiao H, Li H
Pharmacogenomics and Personalized Medicine 2023, 16:991-1009
Published Date: 9 November 2023
Personalized Approaches to Antiplatelet Treatment for Cardiovascular Diseases: An Umbrella Review
Oliva A, Cao D, Spirito A, Nicolas J, Pileggi B, Kamaleldin K, Vogel B, Mehran R
Pharmacogenomics and Personalized Medicine 2023, 16:973-990
Published Date: 3 November 2023
Identification of a Prognostic Gene Signature Based on Lipid Metabolism-Related Genes in Esophageal Squamous Cell Carcinoma
Shen GY, Yang PJ, Zhang WS, Chen JB, Tian QY, Zhang Y, Han B
Pharmacogenomics and Personalized Medicine 2023, 16:959-972
Published Date: 4 November 2023
Hepatic Artery Infusion Chemotherapy Sequential Hepatic Artery Embolization Combined with Operation in the Treatment of Recurrent Massive Hepatocellular Carcinoma Achieved Pathological Complete Response: A Case Report
Chen J, Liao X, Wu Y, Ou S, Qin W, Yang C, Tan Y, Lao Q, Peng M, Peng T, Ye X
Pharmacogenomics and Personalized Medicine 2023, 16:949-958
Published Date: 1 November 2023
rs217727 of lncRNA H19 is Associated with Cervical Cancer Risk in the Chinese Han Population
Dai J, Zhang S, Shi Y, Xu J, Liu W, Yang J, Shi L, Yan Z, Li C
Pharmacogenomics and Personalized Medicine 2023, 16:933-948
Published Date: 30 October 2023
Association Between CTSK Gene Polymorphisms and Response to Alendronate Treatment in Postmenopausal Chinese Women with Low Bone Mineral Density
Yuan H, Wang C, Liu L, Wang C, Zhang Z, Qu S
Pharmacogenomics and Personalized Medicine 2023, 16:925-932
Published Date: 28 October 2023
Microarray Expression Profile and Bioinformatic Analysis of Circular RNA in Human Arteriosclerosis Obliterans
Zhou Y, Cai H, Huang L, Wang M, Liu R, Wang S, Qin Y, Yao C, Hu Z
Pharmacogenomics and Personalized Medicine 2023, 16:913-924
Published Date: 24 October 2023
A Case Report of Cardiofaciocutaneous Syndrome with MAP2K1 Pathogenic Variant [Letter]
Furqoni AH, Fajarwati I, Poetranto AL
Pharmacogenomics and Personalized Medicine 2023, 16:911-912
Published Date: 25 October 2023
Influence of CYP450 Enzymes and ABCB1 Polymorphisms on Clopidogrel Response in Moroccan Patients with Acute Coronary Syndromes
Mouhrach I, Bouguenouch L, Kamal A, Meriame A, El Khorb N, El Azami El Idrissi M, Akoudad H, Bekkari H
Pharmacogenomics and Personalized Medicine 2023, 16:901-909
Published Date: 2 October 2023